According to my chart, TLX closed at $12.50 on 22/6 last year....

According to my chart, TLX closed at $12.50 on 22/6 last year. This was at the peak of the run that started a few months earlier. The intraday price peaked at $12.75, and only that day and the following did the price get over $12.50 at any point.

On 29/2 the price closed at $12.44 and that late Feb period was the first time in a while the price got close to that $12.50 mark. Now, for the second time, the close is at $12.50

How much of a resistance that $12.50 is remains to be seen. The price action in 2024 has a very "breakout pennant" sort of vibe.

In response to @mnbvcxz12345 I completely agree that TLX is not being priced for growth. But again I think ASX investors are conservative and have a believe-it-when-they-see-it approach.

Just popped over to see that PME has $10b market cap based on ~$150m annualised sales. But then they pay about $30-40m of that out on dividends. It's only software innit? When I flicked through the anual report I couldn't find a line item for R&D, I guess it's all bundled into their staff costs. (and given they talk about AI radiology imaging they must be doing some sort of R&D, hmm?)

Now PME's business model is going to be very different to TLX. I think the fact that the outgoings are much much lower, and it pays a dividend, makes it much more a model that the ASX understands.

But still, there's a company that's priced for growth.